Evidence map›Paper›PMID 23643533›Full record

ArticleCell reports2013

Generation of integration-free and region-specific neural progenitors from primate fibroblasts.

Jianfeng Lu, Huisheng Liu, Cindy Tzu-Ling Huang, Hong Chen, Zhongwei Du, Yan Liu, Mohammad Amin Sherafat, Su-Chun Zhang

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 103 citations in OpenAlex.

  1. NEUROD1 efficiently converts peripheral blood cells into neurons with partial reprogramming by pluripotency factors.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Next-generation direct reprogramming.Frontiers in cell and developmental biology · 2024
    Review
  3. Article
  4. Uncovering the role of FOXA2 in the Development of Human Serotonin Neurons.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  5. Review
  6. iPSCs-Derived Neurons and Brain Organoids from Patients.Handbook of experimental pharmacology · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Accelerated neuronal agingFrontiers in aging neuroscience · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Therapeutic Plasticity of Neural Stem Cells.Frontiers in neurology · 2020
    Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jianfeng LuDepartment of Neuroscience, School of Medicine and Public Health, Waisman Center, University of Wisconsin, Madison, Madison, WI 53705, USA.
Huisheng Liu
Cindy Tzu-Ling Huang
Hong Chen
Zhongwei Du
Yan Liu
Mohammad Amin Sherafat
Su-Chun Zhang
University of Wisconsin–Madison · US

Funding

WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
WISCONSIN CENTER ON MENTAL RETARDATION: CORE SUPPORTP30HD003352 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI MESSING, ALBEE · 1985 to 2015
$25.2M
Summer Research ExperienceP50MH100031 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI KALIN, NED H · 2013 to 2017
$10.4M
Neural Specification of Embryonic Stem CellsR01NS045926 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ZHANG, SU-CHUN · 2003 to 2013
$3.5M
Individualized Cell Therapy for Parkinson's DiseaseR01NS076352 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ZHANG, SU-CHUN · 2012 to 2016
$3.1M
Disease Pluripotent Stem (iPS) CellsR21NS064578 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ZHANG, SU-CHUN · 2009 to 2010
$408k
Reprogramming of disease motor neuronsR21NS074189 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI DU, ZHONGWEI · 2011 to 2012
$408k
NICHD NIH HHS P30 HD003352NICHD NIH HHS P30 HD03352NIH HHS P51 OD011106NIMH NIH HHS P50 MH100031NINDS NIH HHS NS04596NINDS NIH HHS NS064578NINDS NIH HHS NS074189NINDS NIH HHS R01 NS045926NINDS NIH HHS R01 NS076352NINDS NIH HHS R21 NS064578NINDS NIH HHS R21 NS074189
6 · The paper itself

Abstract

Postnatal and adult human and monkey fibroblasts were infected with Sendai virus containing the Yamanaka factors for 24 hr, then they were cultured in a chemically defined medium containing leukemia inhibitory factor (LIF), transforming growth factor (TGF)-β inhibitor SB431542, and glycogen synthase kinase (GSK)-3β inhibitor CHIR99021 at 39°C for inactivation of the virus. Induced neural progenitor (iNP) colonies appeared as early as day 13 and can be expanded for >20 passages. Under the same defined condition, no induced pluripotent stem cell (iPSC) colonies formed at either 37°C or 39°C. The iNPs predominantly express hindbrain genes and differentiate into hindbrain neurons, and when caudalized, they produced an enriched population of spinal motor neurons. Following transplantation into the forebrain, the iNP-derived cells retained the hindbrain identity. The ability to generate defined, integration-free iNPs from adult primate fibroblasts under a defined condition with predictable fate choices will facilitate disease modeling and therapeutic development.

Indexed as

AnimalsBenzamidesCell DifferentiationDioxolesFibroblastsHaplorhiniHumansInduced Pluripotent Stem CellsLeukemia Inhibitory FactorNeural Stem CellsNeurogliaNeuronsProsencephalonPyridinesPyrimidinesRhombencephalon4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideBenzamidesChir 99021DioxolesLeukemia Inhibitory FactorPyridinesPyrimidines

Identifiers

PMID23643533
PMCPMC3786191
OpenAlexW2030396039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.